Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?

por Taskinen, Marja-Riitta, Borén, Jan
Publicado 2016

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

por Taskinen, Marja-Riitta, Packard, Chris J., Borén, Jan
Publicado 2019

Dietary Fructose and the Metabolic Syndrome

por Taskinen, Marja-Riitta, Packard, Chris J, Borén, Jan
Publicado 2019

Causes and Consequences of Hypertriglyceridemia

por Packard, Chris J., Boren, Jan, Taskinen, Marja-Riitta
Publicado 2020

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

por Borén, Jan, Packard, Chris J., Taskinen, Marja-Riitta
Publicado 2020

Effect of HDL composition and particle size on the resistance of HDL to the oxidation

por Shuhei, Nakanishi, Söderlund, Sanni, Jauhiainen, Matti, Taskinen, Marja-Riitta
Publicado 2010

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans

por Adiels, Martin, Mardinoglu, Adil, Taskinen, Marja-Riitta, Borén, Jan
Publicado 2015

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects

por Kahri, Juhani, Soro-Paavonen, Aino, Ehnholm, Christian, Taskinen, Marja-Riitta
Publicado 2006

A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects model

por Krengel, Annette, Hauth, Jan, Taskinen, Marja-Riitta, Adiels, Martin, Jirstrand, Mats
Publicado 2013

Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects Models

por Berglund, Martin, Adiels, Martin, Taskinen, Marja-Riitta, Borén, Jan, Wennberg, Bernt
Publicado 2015

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

por Forsblom, Carol, Hiukka, Anne, Leinonen, Eeva S., Sundvall, Jouko, Groop, Per-Henrik, Taskinen, Marja-Riitta
Publicado 2010

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study

por Björnson, Elias, Adiels, Martin, Taskinen, Marja-Riitta, Burgess, Stephen, Rawshani, Aidin, Borén, Jan, Packard, Chris J
Publicado 2023

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized contr...

por Matikainen, Niina, Söderlund, Sanni, Björnson, Elias, Pietiläinen, Kirsi, Hakkarainen, Antti, Lundbom, Nina, Taskinen, Marja‐Riitta, Borén, Jan
Publicado 2018

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Interven...

por Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Publicado 2009

High-resolution population-specific recombination rates and their effect on phasing and genotype imputation

por Hassan, Shabbeer, Surakka, Ida, Taskinen, Marja-Riitta, Salomaa, Veikko, Palotie, Aarno, Wessman, Maija, Tukiainen, Taru, Pirinen, Matti, Palta, Priit, Ripatti, Samuli
Publicado 2020

Apolipoprotein C‐III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria

por Jansson Sigfrids, Fanny, Stechemesser, Lars, Dahlström, Emma H., Forsblom, Carol M., Harjutsalo, Valma, Weitgasser, Raimund, Taskinen, Marja‐Riitta, Groop, Per‐Henrik
Publicado 2021

Variation in GYS1 Interacts with Exercise and Gender to Predict Cardiovascular Mortality

por Fredriksson, Jenny, Anevski, Dragi, Almgren, Peter, Sjögren, Marketa, Lyssenko, Valeriya, Carlson, Joyce, Isomaa, Bo, Taskinen, Marja-Riitta, Groop, Leif, Orho-Melander, Marju
Publicado 2007

Cardiac steatosis and left ventricular function in men with metabolic syndrome

por Nyman, Kristofer, Granér, Marit, Pentikäinen, Markku O, Lundbom, Jesper, Hakkarainen, Antti, Sirén, Reijo, Nieminen, Markku S, Taskinen, Marja-Riitta, Lundbom, Nina, Lauerma, Kirsi
Publicado 2013

Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

por Bunck, Mathijs C., Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M., Heine, Robert J., Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf
Publicado 2010

High Density Lipoprotein Structural Changes and Drug Response in Lipidomic Profiles following the Long-Term Fenofibrate Therapy in the FIELD Substudy

por Yetukuri, Laxman, Huopaniemi, Ilkka, Koivuniemi, Artturi, Maranghi, Marianna, Hiukka, Anne, Nygren, Heli, Kaski, Samuel, Taskinen, Marja-Riitta, Vattulainen, Ilpo, Jauhiainen, Matti, Orešič, Matej
Publicado 2011